In Vitro and In Vivo SERS Biosensing for Disease Diagnosis
AbstractFor many disease states, positive outcomes are directly linked to early diagnosis, where therapeutic intervention would be most effective. Recently, trends in disease diagnosis have focused on the development of label-free sensing techniques that are sensitive to low analyte concentrations found in the physiological environment. Surface-enhanced Raman spectroscopy (SERS) is a powerful vibrational spectroscopy that allows for label-free, highly sensitive, and selective detection of analytes through the amplification of localized electric fields on the surface of a plasmonic material when excited with monochromatic light. This results in enhancement of the Raman scattering signal, which allows for the detection of low concentration analytes, giving rise to the use of SERS as a diagnostic tool for disease. Here, we present a review of recent developments in the field of in vivo and in vitro SERS biosensing for a range of disease states including neurological disease, diabetes, cardiovascular disease, cancer, and viral disease. View Full-Text
Share & Cite This Article
Moore, T.J.; Moody, A.S.; Payne, T.D.; Sarabia, G.M.; Daniel, A.R.; Sharma, B. In Vitro and In Vivo SERS Biosensing for Disease Diagnosis. Biosensors 2018, 8, 46.
Moore TJ, Moody AS, Payne TD, Sarabia GM, Daniel AR, Sharma B. In Vitro and In Vivo SERS Biosensing for Disease Diagnosis. Biosensors. 2018; 8(2):46.Chicago/Turabian Style
Moore, T. J.; Moody, Amber S.; Payne, Taylor D.; Sarabia, Grace M.; Daniel, Alyssa R.; Sharma, Bhavya. 2018. "In Vitro and In Vivo SERS Biosensing for Disease Diagnosis." Biosensors 8, no. 2: 46.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.